Related Experiment Videos
Viral vectors for gene transfer into antigen presenting cells
1Immunotherapy Division, Northwest Biotherapeutics Inc, 120 Northgate Plaza, Seattle, WA 98125, USA.
Current Opinion in Molecular Therapeutics
|March 16, 2001
Summary
Vaccine development benefits from studying immune responses to vaccines and viral vectors. Targeting dendritic cells with viral vectors shows promise for effective T- and B-cell immunity in clinical trials.
Area of Science:
- Immunology
- Vaccinology
- Gene Therapy
Background:
- Understanding immune system responses is crucial for developing effective vaccines.
- Antigen delivery methods and presentation to lymphocytes significantly impact vaccine efficacy.
Purpose of the Study:
- To explore the role of dendritic cells in vaccine development.
- To evaluate the potential of viral vectors for antigen delivery and immune stimulation.
Main Methods:
- Examining immune responses to antimicrobial vaccines and viral vectors.
- Focusing on antigen delivery to dendritic cells for enhanced immune responses.
- Utilizing recombinant viral vectors to deliver genes encoding antigens.
Main Results:
- Dendritic cell targeting promotes clinically beneficial T- and B-cell responses.
- Recombinant viral vectors effectively deliver antigens to induce immunity.
- Dendritic cell-based and viral vector-based vaccines are in clinical trials.
Conclusions:
- Targeting dendritic cells with viral vectors is a promising strategy for vaccine development.
- Viral vector-based vaccines show potential for inducing antitumor immunity.